首页> 中文期刊> 《中外医疗》 >终末期肝病模型对肝硬化腹水患者并发自发性腹膜炎的预测价值评估

终末期肝病模型对肝硬化腹水患者并发自发性腹膜炎的预测价值评估

         

摘要

目的:探讨终末期肝病模型(MELD)对于肝硬化腹水合并自发性腹膜炎(SBP)的临床预测价值。方法收集肝硬化腹水患者127例,根据是否合并SBP分为SBP组(33例)和非SBP组(94例),比较两组的MELD评分;并根据MELD评分分为A组(≤9分)、B组(10~19分)、C组(20~29组)和D组(≥30分),比较5组SBP发生率。结果 SBP组的MELD得分显著高于非SBP组(P<0.05);MELD得分与SBP发生率呈显著正相关性(P<0.05)。结论 MELD评分对于肝硬化腹水发生SBP具有重要的临床预测价值,MELD得分与SBP发生率呈正相关性。%Objective To investigate the clinical predictive value of model for end-stage liver disease (MELD) for liver cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods 127 cases of patients with liver cirrhosis were divided into SBP group(33 cases) and non-SBP group (94 cases) according to whether the patients complicated by SBP. The MELD scores of the two groups were compared; and the patients were divided into group A (≤9 points), group B (10-19 points), group C (20-29 points) and group D (≥30 points) in accordance with the MELD score, and the incidences of SBP of five groups were compared. Results The MELD score of SBP group was significantly higher than that of non-SBP group (P<0.05); MELD score and the incidence of SBP was significantly positively correlated (P<0.05). Conclusion MELD score has important clinical predictive value for liver cir-rhosis complicated by SBP, and it is positively correlated with the incidence of SBP.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号